Elevance Health Inc (NYSE:ELV) currently has a daily average trading volume of 1.80M but it saw 1248038 shares traded in last market. With a market cap of 86.07B USD, the company’s current market price of $380.93 came falling about -0.78 while comparing to the previous closing price of $383.92. In past 52 weeks, the stock remained buoying in the range of price level as high as $567.26 and as low as $357.45.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Robert W. Baird which downgraded the stock as “Neutral” in its note to investors issued on April 15, 2025, recommending a price target of $529 for it. Argus upgraded its recommendation for the stock as a “Buy” from “Hold” on March 17, 2025 while assigning a price target of $450. Stephens also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $520 and $440.
Over the week, ELV’s stock price is moving 0.23% up while it is -8.58% when we observe its performance for the past one month. Year-to-date it is 3.26% up and over the past year, the stock is showing a downside performance of -29.32%.
Currently, Elevance Health Inc’s total number of outstanding shares is 225.64M. Company’s return on investment (ROI) stands at 8.38% and return on equity (ROE) at 14.24%. It has a price to earnings ratio (P/E ratio) of 14.86 while having a 9.72 of forward P/E ratio. Stock’s beta reads 0.62. Stock has a price to book (P/B) ratio of 2.02 while price to sale or P/S ratio amounts to 0.47. Its return on asset (ROA) is 5.11% on average.
